Company: PRME
Filing Date: 2025-07-30
Form Type: 8-K
Source: 0001628280-25-036705
Chunk: 3

Company: Prime Medicine, Inc.
Filing Date: 2025-07-30
Form: 8-K
Item: Item 8.01
Chunk 3
---
8-K. These and other risks and uncertainties are described in greater detail in the section entitled “ Risk Factors” in the Company’s most recent Annual Report on Form 10-K for the year ended December 31, 2024, Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, and any of its subsequent filings with the Securities and Exchange Commission. In addition, any forward-looking statements represent the Company’s views only as of today and should not be relied upon as representing its views as of any subsequent date. The Company explicitly disclaims any

obligation to update any forward-looking statements. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements, except as required by law.

Item 9.01 - Financial Statements and Exhibits